Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Elevated superoxide production by active H-ras enhances human lung WI-38VA-13 cell proliferation, migration and resistance to TNF-α

Abstract

Accumulating evidence has suggested that cellular production of superoxide acts as an intracellular messenger to regulate gene expression and modulate cellular activities. In this report, we set out to investigate the role of active H-ras-mediated superoxide production on tumor cell malignancy in a SV-40 transformed human lung WI-38 VA-13 cell line. Stable transfection and expression of constitutively active mutant V12-H-ras (V12-H-ras) dramatically increased intracellular production of superoxide. The expression of V12-H-ras significantly enhanced cell proliferation, migration and resistance to TNF-α treatment compared to that of parental and vector control cells, while expression of wild type H-ras (WT-H-ras) only had modest effects. Upon scavenging by superoxide dismutase and other molecules that decrease the intracellular level of active H-ras mediated superoxide production, cell proliferation, migration and resistance to TNF-α were significantly reduced. Furthermore, we demonstrated that the activation of membrane NADPH oxidase activity by expression of active H-ras contributed to the intracellular superoxide production. The causal relationship between membrane superoxide production and increased cell proliferation, migration, and resistance to TNF-α by the expression of active H-ras, has provided direct evidence to demonstrate that superoxide acts as an intracellular messenger to cascade ras oncogenic signal relay and to modulate tumor malignant activity.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Adler V, Yin Z, Tew KD, Ronai Z . 1999 Oncogene 18: 6104–6111

  • Ames BN, Shigenaga MK, Hagen TM . 1993 Proc. Natl. Acad. Sci. USA 90: 7915–7922

  • Atlante A, Calissano P, Bobba A, Azzariti A, Marra E, Passarella S . 2000 J. Biol. Chem. 275: 37159–37166

  • Bae YS, Sung J-Y, Kim O-S, Kim YJ, Hur KC, Kazlauskas A, Rhee SG . 2000 J. Biol. Chem. 275: 10527–10531

  • Bohler T, Waiser J, Hepburn H, Gaedeke J, Lehmann C, Hambach P, Budde K, Neumayer HH . 2000 Cytokine 12: 986–991

  • Brunet A, Pouyssenur J . 1996 Science 272: 1652–1655

  • Buettner GR . 1993 Arch. Biochem. Biophys. 300: 535–543

  • Cerutti PA . 1985 Science 227: 375–381

  • Clement M-V, Stamenkovi I . 1996 EMBO J. 15: 216–225

  • Crawford LE, Milliken EE, Irani K, Zweier JL, Becker LC, Johnson TM, Eissa NT . 1996 J. Biol. Chem. 271: 26863–26867

  • Dagher MC, Fuchs A, Bourmeyster N, Jouan A, Vignais PV . 1995 Biochimie 77: 651–660

  • Diekmann D, Abo A, Johnston C, Segal AW, Hall A . 1994 Science 265: 531–533

  • Emerit I, Cerutti PA . 1981 Nature 293: 144–146

  • Floyd RA . 1999 Proc. Soc. Exp. Biol. Med. 222: 236–245

  • Freeman JL, Abo A, Lambeth JD . 1996 J. Biol. Chem. 271: 19794–19801

  • Fridovich I . 1983 Ann. Rev. Pharma. Toxicol. 23: 239–257

  • Giri U, Iqbal M, Agarwal MK, Khan S, Athar M . 1999 Cancer Letter 135: 53–60

  • Hildeman DA, Mitchell T, Teague TK, Henson P, Day BJ, Kappler J, Marrack PC . 1999 Immunity 10: 735–744

  • Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W . 2000 Nature 407: 390–395

  • Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, Goldschmidt-Clermont PJ . 1997 Science 275: 1649–1652

  • Irani K, Goldchmidt-Clermont PJ . 1998 Biochem. Pharma. 55: 1339–1346

  • Iwata K, Shibuya H, Ohkawa Y, Inui N . 1984 Toxicol. Letter 22: 75–81

  • Jaruga P, Zastawny TH, Skokowski J, Dizdroglu M, Olinski R . 1994 FEBS Lett. 341: 59–64

  • Jones SA, Wood JD, Coffey MJ, Jones OT . 1994 FEBS Lett. 355: 178–182

  • Jones SA, O'Donnell VB, Wood JD, Broughton JP, Hughes EJ, Jones OT . 1996 Am. J. Physiol. 271: H1626–H1634

  • Joneson T, McDonough M, Bar-Sagi D, Van Aelst L . 1996 Science 274: 1374–1376

  • Kamata H, Tanaka C, Yagisawa H, Matsuda S, Gotoh Y, Nishda E, Hirata H . 1996 J. Biol. Chem. 271: 33018–33025

  • Kennedy AR, Troll W, Little JB . 1984 Carcinogenesis 5: 1213–1218

  • Kheradmand F, Werner E, Tremble P, Symons M, Werb Z . 1998 Science 280: 898–902

  • Krieger-Brauer HI, Kather H . 1995a Biochem. J. 307: 543–548

  • Krieger-Brauer HI, Kather H . 1995b Biochem. J. 307: 549–556

  • Lee AC, Fenster BE, Ito H, Takeda K, Bae NS, Hirai T, Yu ZX, Ferrans VJ, Howard BH, Finkel T . 1999 J. Biol. Chem. 274: 7936–7940

  • Li N, Oberley TD, Oberley LW, Zhong W . 1998 Prostate 35: 221–233

  • Li S, Yan T, Yang JQ, Oberley TD, Oberley LW . 2000 Cancer Res. 60: 3927–3939

  • Liu R, Oberley TD, Oberley LW . 1997 Human Gene Therapy 8: 585–595

  • Liu R, Oberley TD, Oberley LW . 1998 Cell Growth Differ. 9: 239–246

  • Liu R, Narla RK, Kurinov I, Li B, Uckun FM . 1999 Rad. Res. 151: 133–141

  • Liu R, Buettner GR, Oberley LW . 2000 Free Rad. Biol. Med. 28: 1197–1205

  • Lo YYC, Cruz TF . 1995 J. Biol. Chem. 270: 11727–11730

  • Loschen G, Azzi A, Richter C, Flohe L . 1974 FEBS Letts. 42: 6874–6880

  • Meier B, Radeke HH, Selle S, Younes M, Sies H, Resch K, Habermehl GG . 1989 Biochem. J. 263: 539–545

  • Moldovan L, Moldovan NI, Sohn RH, Parikh SA, Goldschmidt-Clermont PJ . 2000 Circulation Res. 86: 549–557

  • Nakamura Y, Colburn NH, Gindhardt TD . 1985 Carcinogenesis 6: 229–235

  • Oberley LW, Buettner GR . 1979 Cancer Res. 39: 1141–1149

  • Ohba M, Shibannma M, Kuroki T, Nose KJ . 1994 J. Cell Biol. 126: 1079–1088

  • Pani G, Bedogni B, Anzevino R, Colavitti R, Palazzotti B, Borrello S, Galeotti T . 2000 Cancer Res. 60: 4654–4660

  • Pick E . 1986 Meth. Enzymol. 132: 407–421

  • Pretone WF, English DK, Wong K, McCord JM . 1980 Proc. Natl. Acad. Sci. USA 77: 1159–1165

  • Qiu R, Chen D, Kim D, McCormick F, Symons M . 1995 Nature 374: 457–460

  • Quinn M . 1995 J. Leukocyte Biol. 58: 263–276

  • Sofuni T, Ishidate Jr M . 1984 Mutation Res. 140: 27–31

  • Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Fankel T . 1995 Science 270: 296–299

  • Thannickal VJ, Aldweib KDL, Fanburg BL . 1998 J. Biol. Chem. 273: 23611–23615

  • Ward RA, Nakamura M, McLeish KR . 2000 J. Biol. Chem. 275: 36713–36719

  • Yan T, Oberley LW, Zhong W, St. Clair DK . 1996 Cancer Res. 56: 2864–2871

  • Yang J-Q, Li S, Domann FE, Buettner GR, Oberley LW . 1999 Molec. Carcinogen. 26: 180–188

  • Zhai Q, Ji H, Zheng Z, Yu X, Sun L, Liu X . 2000 J. Cell. Physiol. 184: 161–170

  • Zhong W, Oberley LW, Oberley TD, St. Clair DK . 1997 Oncogene 14: 481–490

  • Zimmerman R, Cerutti PA . 1984 Proc. Natl. Acad. Sci. USA 81: 2085–2087

Download references

Acknowledgements

We thank Mr Geoff Modderman for his suggestion and technical assistance on the preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, R., Li, B. & Qiu, M. Elevated superoxide production by active H-ras enhances human lung WI-38VA-13 cell proliferation, migration and resistance to TNF-α. Oncogene 20, 1486–1496 (2001). https://doi.org/10.1038/sj.onc.1204214

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204214

Keywords

This article is cited by

Search

Quick links